Current Report Filing (8-k)
May 18 2020 - 4:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 14, 2020
Kewaunee Scientific Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
Delaware
|
|
0-5286
|
|
38-0715562
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
2700 West Front Street
Statesville, North Carolina
|
|
28677
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code: 704-873-7202
N/A
(Former name or
former address, if changed since last report.)
Securities registered pursuant
to Section 12(b) of the Act:
|
|
|
|
|
|
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange
on which
registered
|
|
Common Stock, $2.50 par value
|
|
KEQU
|
|
NASDAQ Global Market
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 1.02
|
Termination of a Material Definitive Agreement.
|
On May 14, 2020, following review of guidance issued by the United States Treasury Department and the U.S. Small Business Administration on May 6,
2020, Kewaunee Scientific Corporation (the “Company”) returned all funds it previously received pursuant to the Paycheck Protection Program (“PPP”) established under the Coronavirus Aid, Relief, and Economic Security Act. The
loan was approved on May 3, 2020 and received on May 7, 2020, as described in a Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on May 7, 2020.
In light of the return of the funds from the PPP loan, the Company no longer intends to file with the SEC a copy of the related promissory note as an
exhibit to the Company’s Form 10-K for the fiscal year ended April 30, 2020.
Signature
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
Kewaunee Scientific Corporation
|
|
|
|
|
|
Date: May 18, 2020
|
|
|
|
/s/ Donald T. Gardner III
|
|
|
|
|
|
Donald T. Gardner III
Vice President, Finance and
Chief Financial Officer
|
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
From Apr 2023 to Apr 2024
